Related Experiment Video
Updated: May 11, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Impact of multidrug-resistant organisms on patients considered for lung transplantation
1Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, 1830 Baltimore, MD 21205, USA. sshoham1@jhmi.edu
Abstract:
Infections with multidrug-resistant organisms are a growing problem in lung transplant recipients. Carriage of drug-resistant bacteria and fungi before transplantation is an important risk factor for such infections. In that regard Pseudomonas aeruginosa and species of Burkholderia, Acinetobacter, non-tuberculous mycobacteria and Scedosporium are particularly important. An understanding of the impact of these organisms is essential to the evaluation of lung transplant candidates. The microbiology, epidemiology, clinical manifestations, and approach to these pathogens before transplant are reviewed in this article.
Insights
Multidrug-resistant organism infections are a significant threat to lung transplant recipients. Pre-transplant carriage of specific bacteria and fungi increases infection risk, necessitating careful candidate evaluation.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Microbiology
Background:
- Multidrug-resistant organisms (MDROs) pose a growing threat to lung transplant recipients.
- Pre-transplant colonization with specific MDROs is a key risk factor for post-transplant infections.
Purpose of the Study:
- To review the microbiology, epidemiology, clinical manifestations, and pre-transplant management of key MDROs in lung transplant candidates.
- To emphasize the importance of understanding these pathogens for effective candidate evaluation.
Main Methods:
- Literature review and synthesis of existing research on MDROs in lung transplantation.
- Focused analysis on specific high-risk organisms including Pseudomonas aeruginosa, Burkholderia species, Acinetobacter species, non-tuberculous mycobacteria, and Scedosporium species.
Main Results:
- Identified key multidrug-resistant bacteria and fungi that are significant pre-transplant risk factors.
- Highlighted the clinical relevance of understanding the epidemiology and manifestations of these pathogens prior to transplantation.
Conclusions:
- Pre-transplant screening and management of MDRO carriage are crucial for improving outcomes in lung transplant recipients.
- A comprehensive understanding of these challenging organisms is essential for optimizing lung transplant candidate selection and care.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Kidney Transplant III: Nursing Management
